Chun Yew Fong

9PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 18, 2025
Final analysis of the phase 1b Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT).

Chong Chyn Chua, Sun Loo, Chun Yew Fong

|Dec 09, 2024
Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromes.

Jacqueline S Garcia, Uwe Platzbecker, Olatoyosi Odenike

|Sep 19, 2024
CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting.

Kelly Lim, Winnie L Kan, Pramod C Nair

|Mar 01, 2024
Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC).

Ing Soo Tiong, Devendra K Hiwase, Emad Abro

|Oct 14, 2023
Reproducible Bioinformatics Analysis Workflows for Detecting IGH Gene Fusions in B-Cell Acute Lymphoblastic Leukaemia Patients.

Ashlee J Thomson, Jacqueline A Rehn, Susan L Heatley

|Sep 21, 2023
Invasive fungal infection following venetoclax and posaconazole co-administration.

Gemma Reynolds, Karen F Urbancic, Chun Y Fong

Pageof 2

Frequent Collaborators

4 joint publications

Ing Soo Tiong

4 joint publications

Andrew H Wei

3 joint publications

Sun Loo

3 joint publications

Natasha S Anstee